CancerNCT02299219
Teens Taking Charge: Managing Cancer Online
A study testing Taking Charge: Managing Cancer Online and Standard Medical Care and Cancer Resource Center in people with Cancer, run by The Hospital for Sick Children at 3 sites in Canada.
Trial summary
Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer. Read more about this study
- Who is it for?
- Ages 12 to 18 years
- Conditions the study is for
- Cancer
- What is being tested?
- Taking Charge: Managing Cancer Online and Standard Medical Care and Cancer Resource Center
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 73 participants
- Where
- 3 sitesCanada
- Study dates
- Jan 2016to 1 Apr 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Parents and adolescents will be eligible to participate if the adolescents are:
- between 12-18 years of age
- diagnosed with cancer (at least 3 months from diagnosis)
- on active treatment
- able to speak and read English and/or French at a Grade 6 level
Who cannot join
- Adolescents will be excluded if they:
- have major cognitive impairments
- have reduced executive function that may impact their ability to understand and use the online program
- are terminal/palliative as determined by their oncologist Parents/caregivers are not eligible to participate in the study alone (without an adolescent)
Trial locations and contacts
3 sites in 1 country.
Canada3 sites
McMaster Children's Hospital
Hamilton, Ontario, L8S 4K1
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5
Children's Hospital Eastern Ontario
Ottawa, Ontario, K1H 8L1
About this study
Official title: Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer
Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer. While two interactive coping websites exist for young people with cancer, they are: (1) not interactive, (2) do not focus on helping youth gain skills for transition and independence, and (3) do not provide opportunities for meaningful social support. In summary, there is a crucial need to develop a comprehensive interactive Internet-based self-management program targeting AWC that is comprised of cancer education, self-management skills, and opportunities for social support, and that is cost-effective.
Read the detailed description
Overall aim of this program of research is to develop and evaluate the "Teens Taking Charge: Managing Cancer Online" Internet intervention that will help AWC to better cope with their disease, improve their HRQL, and enhance readiness to transition to adult health care using a sequential phased approach. The first phase of this project has determined the self-management and transitional care needs of adolescents with cancer. The second phase consisted of website development and usability testing to ensure the website is easy to use and understand, and is efficient and satisfying to complete. Subsequently, we will assess the feasibility of the program and the outcomes from the use of the site in a randomized controlled trial (RCT) pilot study (Phase 3). This will inform the design and methods of the main trial, and will permit us to obtain estimates of treatment effects on AWC health outcomes to inform the calculation of an appropriate sample size for the future definitive RCT (Phase 4). The focus of this study is Phase 3. Phase 4 will be a multicentre randomized controlled trial to assess outcomes for teens that complete the intervention as compared to those of an attention control group.
- Conditions
- Cancer
- Being tested
- Taking Charge: Managing Cancer Online, Standard Medical Care and Cancer Resource Center
- Keywords
- Adolescent, Internet Self-Management, Managing Cancer
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Taking Charge: Managing Cancer OnlineBehavioural
n addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing Cancer Online" Internet self-management program. The intervention is a 12-module interactive multi-component treatment protocol that consists of Cancer-specific education, self-management strategies, and social support that is available in English and French.
Standard Medical Care and Cancer Resource CenterBehavioural
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention. In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about Cancer ("Cancer Resource Centre") and online assessments.
| Study group | Role | What they receive |
|---|---|---|
| Taking Charge Experimental Group | Experimental | Not described Receives: Behavioral: Taking Charge: Managing Cancer Online |
| Control Group | Active comparator | Not described Receives: Behavioral: Standard Medical Care and Cancer Resource Center |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant Accrual and Dropout Rates
These rates will be centrally tracked by the Clinical Research Project Coordinator
Measured: 12 weeks
Fidelity (Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures)
Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the Clinical Research Project Coordinator
Measured: 12 weeks
Acceptability and Satisfaction with Intervention (rate their acceptability of and satisfaction with the intervention)
Post-treatment, adolescents with cancer and their parents in the intervention group will rate their acceptability of and satisfaction with the intervention
Measured: 12 weeks
Engagement with Intervention (Google Analytics will be used to track patterns of website program usage)
Google Analytics will be used to track patterns of website program usage by adolescents with cancer and their parents
Measured: 12 weeks
Secondary outcomes (10)
Knowledge (Adolescent Cancer Knowledge Questionnaire)
Measured using the Adolescent Cancer Knowledge Questionnaire, a 15-item tool that assesses cancer-specific knowledge.
Measured: 12 weeks
Self-Efficacy (Generalized Self-Efficacy-Sherer Scale)
Measured by the Generalized Self-Efficacy-Sherer Scale, a 12-item scale that requires adolescents to indicate their level of agreement with a series of statements about self-efficacy.
Measured: 12 weeks
Treatment adherence (Medication Adherence Scale)
Measured with the Medication Adherence Scale, a 4-item scale for assessing self-reported adherence.
Measured: 12 weeks
Physical Symptoms - Pain (short form Brief Pain Inventory (BPI)
Measured using the short form Brief Pain Inventory (BPI), a 15-item measure that includes scales for measuring pain intensity, impact of pain on functioning and well being, and pain interference.
Measured: 12 weeks
Physical Symptoms - Fatigue (PedsQL Multidimensional Fatigue Module)
Measured using the PedsQL Multidimensional Fatigue Module, an 18-item scale with validated versions for child report (ages 8-12 years), teen report (ages 13-18 years), and parental report for children and teens.
Measured: 12 weeks
Emotional symptoms (Hospital Anxiety and Depression Scale (HADS)
Measured using the Hospital Anxiety and Depression Scale (HADS), a 14-item measure for individuals aged >12 years, which can be completed within 2-5 minutes.
Measured: 12 weeks
Social functioning (Perceived Social Support from Friends (PSS-Fr) Scale)
Measured with the Perceived Social Support from Friends (PSS-Fr) Scale, a 20-item scale that assesses the extent to which an individual perceives that their friends fulfill their needs for support.
Measured: 12 weeks
Transition readiness (Cancer Transition Scales)
Measured with the Cancer Transition Scales, which include sub-scales for 'cancer worry' (6 items), 'self-management skills' (15 items), and 'expectations' (12 items).
Measured: 12 weeks
Health Related Quality of Life (PedsQL Cancer Module)
measured with the PedsQL Cancer Module, a 27-item scale, which has validated versions for child, teen, and parental report, and the Health Utility Index [HUI].
Measured: 12 weeks
Cost effectiveness (ascertaining direct health care costs and family out of pocket costs)
Measured by ascertaining direct health care costs and family out of pocket costs related to cancer care incurred over the 12-week study period using the Health Care Utilization form modified from the Ambulatory and Home Care Record84-90 as well as direct costs related to the online intervention technology, intervention training and personnel. Quality adjusted life years will be calculated using the HUI to determine the incremental cost-effectiveness
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2014 (estimated)
- Study startJan 2016
- Primary completion1 Apr 2019
- Study completion1 Apr 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by The Hospital for Sick ChildrenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 73 participants (actual)
Sponsor and investigators
- Lead sponsor
- The Hospital for Sick Children
- Sponsor type
- University, hospital or other
- Collaborators
- Université de Montréal, Children's Hospital of Eastern Ontario, St. Justine's Hospital, Hamilton Health Sciences Corporation, Institute for Clinical Evaluative Sciences, McGill University, McMaster University, University of Alberta
- Responsible party
- Principal investigator, Jennifer Stinson, The Hospital for Sick Children
- Investigators
- Jennifer N Stinson, PhD, CPNP, Principal investigator, The Hospital for Sick Children
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02299219
- Sponsor's protocol ID
- 1000045896
- Status last verified
- Oct 2019
- First submitted
- 17 Nov 2014
- Last updated
- 9 Oct 2019
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer
- ClinicalTrials.gov ID
- NCT02299219
- Acronym / sponsor ID
- 1000045896
- Conditions
- Cancer
- Keywords
- Adolescent, Internet Self-Management, Managing Cancer
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 73 participants (actual)
- Lead sponsor
- The Hospital for Sick ChildrenUniversity, hospital or other
- Collaborators
- Université de Montréal, Children's Hospital of Eastern Ontario, St. Justine's Hospital, Hamilton Health Sciences Corporation, Institute for Clinical Evaluative Sciences, McGill University, McMaster University, University of Alberta
- Study start
- Jan 2016 (actual)
- Primary completion
- 1 Apr 2019 (actual)
- Study completion
- 1 Apr 2019 (actual)
- First posted
- 24 Nov 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer. While two interactive coping websites exist for young people with cancer, they are: (1) not interactive, (2) do not focus on helping youth gain skills for transition and independence, and (3) do not provide opportunities for meaningful social support. In summary, there is a crucial need to develop a comprehensive interactive Internet-based self-management program targeting AWC that is comprised of cancer education, self-management skills, and opportunities for social support, and that is cost-effective.
Detailed description
Overall aim of this program of research is to develop and evaluate the "Teens Taking Charge: Managing Cancer Online" Internet intervention that will help AWC to better cope with their disease, improve their HRQL, and enhance readiness to transition to adult health care using a sequential phased approach. The first phase of this project has determined the self-management and transitional care needs of adolescents with cancer. The second phase consisted of website development and usability testing to ensure the website is easy to use and understand, and is efficient and satisfying to complete. Subsequently, we will assess the feasibility of the program and the outcomes from the use of the site in a randomized controlled trial (RCT) pilot study (Phase 3). This will inform the design and methods of the main trial, and will permit us to obtain estimates of treatment effects on AWC health outcomes to inform the calculation of an appropriate sample size for the future definitive RCT (Phase 4). The focus of this study is Phase 3. Phase 4 will be a multicentre randomized controlled trial to assess outcomes for teens that complete the intervention as compared to those of an attention control group.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Taking Charge Experimental Group | Experimental | Behavioral: Taking Charge: Managing Cancer Online |
| Control Group | Active comparator | Behavioral: Standard Medical Care and Cancer Resource Center |
Who may qualify
- Ages
- 12 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (5 listed)
- Parents and adolescents will be eligible to participate if the adolescents are:
Key exclusion criteria (4 listed)
- Adolescents will be excluded if they:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Taking Charge: Managing Cancer Onlinen addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing Cancer Online" Internet self-management program. The intervention is a 12-module interactive multi-component treatment protocol that consists of Cancer-specific education, self-management strategies, and social support that is available in English and French. | Behavioural | Taking Charge Experimental Group |
| Standard Medical Care and Cancer Resource CenterThe control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention. In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about Cancer ("Cancer Resource Centre") and online assessments. | Behavioural | Control Group |
Primary outcome
Participant Accrual and Dropout Rates
Time frame: 12 weeks
These rates will be centrally tracked by the Clinical Research Project Coordinator
Fidelity (Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures)
Time frame: 12 weeks
Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the Clinical Research Project Coordinator
Acceptability and Satisfaction with Intervention (rate their acceptability of and satisfaction with the intervention)
Time frame: 12 weeks
Post-treatment, adolescents with cancer and their parents in the intervention group will rate their acceptability of and satisfaction with the intervention
Engagement with Intervention (Google Analytics will be used to track patterns of website program usage)
Time frame: 12 weeks
Google Analytics will be used to track patterns of website program usage by adolescents with cancer and their parents
10 secondary outcomes
Knowledge (Adolescent Cancer Knowledge Questionnaire)
Time frame: 12 weeks
Self-Efficacy (Generalized Self-Efficacy-Sherer Scale)
Time frame: 12 weeks
Treatment adherence (Medication Adherence Scale)
Time frame: 12 weeks
Physical Symptoms - Pain (short form Brief Pain Inventory (BPI)
Time frame: 12 weeks
Physical Symptoms - Fatigue (PedsQL Multidimensional Fatigue Module)
Time frame: 12 weeks
Emotional symptoms (Hospital Anxiety and Depression Scale (HADS)
Time frame: 12 weeks
Social functioning (Perceived Social Support from Friends (PSS-Fr) Scale)
Time frame: 12 weeks
Transition readiness (Cancer Transition Scales)
Time frame: 12 weeks
Health Related Quality of Life (PedsQL Cancer Module)
Time frame: 12 weeks
Cost effectiveness (ascertaining direct health care costs and family out of pocket costs)
Time frame: 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2019.
Related trials for Cancer
RecruitingPhase 1
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
Solid Tumor
RecruitingPhase 1
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer N Stinson, PhD, CPNP principal investigator
The Hospital for Sick Children
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Taking Charge: Managing Cancer Online and Standard Medical Care and Cancer Resource Center in people with Cancer, run by The Hospital for Sick Children at 3 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant Accrual and Dropout Rates (time frame: 12 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2019.